Kenney CT, Marraffini LA.  2023.  Rarely acquired type II-A CRISPR-Cas spacers mediate anti-viral immunity through the targeting of a non-canonical PAM sequence.. Nucleic Acids Res. 51(14):7438-7450.

Şenbabaoğlu Y, Gejman RS, Winer AG, Liu M, Van Allen EM, de Velasco G, Miao D, Ostrovnaya I, Drill E, Luna A et al..  2016.  Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures.. Genome Biol. 17(1):231.

Loeb GB, Khan AA, Canner D, Hiatt JB, Shendure J, Darnell RB, Leslie CS, Rudensky AY.  2012.  Transcriptome-wide miR-155 binding map reveals widespread noncanonical microRNA targeting.. Mol Cell. 48(5):760-70.